Emsight

Company Overview

Snapshot

Founded in July 2024 by Ido Goldberg and Refael Minnes, Emsight operates with 1–10 employees. The company has raised $400,000 across one funding round. In September 2024, Emsight secured a grant from the Israel Innovation Authority.

Business overview

Emsight is developing groundbreaking vision technology to revolutionize eye care. The company focuses on pioneering non-invasive cataract treatment solutions, providing ophthalmologists with cutting-edge technology to address the root cause of cataracts without surgery. Its innovative medical device, based on non-ionizing electromagnetic radiation, offers a safer, more cost-effective alternative to traditional procedures. Designed for ease of use and accessibility, Emsight's technology empowers eye clinics to deliver advanced care to patients across various stages of cataract development, with minimal recovery time, operating within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

When was Emsight founded?

Emsight was founded in July 2024.

Who are the founders of Emsight?

Ido Goldberg and Refael Minnes are the co-founders of Emsight.

What is Emsight's primary focus in the healthcare sector?

Emsight is focused on developing groundbreaking, non-invasive cataract treatment solutions using an innovative medical device based on non-ionizing electromagnetic radiation.

What is the total capital raised by Emsight?

Emsight has raised a total of $400,000 across one funding round.

Has Emsight received any grants?

In September 2024, Emsight secured a grant from the Israel Innovation Authority.